AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Impact of Satiating Compounds and Hypocaloric Diet on Weight, Cardiometabolic and Osteoarticular Health in Obesity

RecruitingNAAges 18 Years - 65 YearsAllClinica Universidad de Navarra, Universidad de Naโ€ฆ
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

The main objective of this intervention study is to evaluate the effect of satiating protein and/or fiber bar consumption on weight loss and other osteoarticular and cardiometabolic parameters related to excess weight in subjects with overweight or obesity. To achieve this objective, volunteers will be instructed to consume three bars per day as part of a hypocaloric diet, in accordance with healthy nutritional guidelines, over a 12-week period. The main questions to answer are: * Does the regular consumption of these protein and/or fiber bars help to lose weight? * Does the regular consumption of these protein and/or fiber bars help to improve the osteoarticular health? * Does the regular consumption of these protein and/or fiber bars help to improve the cardiometabolic health? The specific objectives are focused on evaluating the effects of the intervention on the following paramet

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Volunteers of both sexes between the ages of 18 and 65 years old. * Volunteers with grade II overweight or obesity (BMI: 27.0-39.9 kg/m2). * Physical examination and vital signs are normal or clinically irrelevant to the study. * Volunteers receiving pharmacological treatment may be included if the dosage has remained stable for at least three months prior to study initiation. * Individuals undergoing treatment for diabetes will be excluded. * Participants must be capable of understanding the study requirements, willing to provide written informed consent, and able to comply with all study procedures and timelines. * Body weight must have remained stable (ยฑ5%) during the three months preceding study initiation. Exclusion Criteria: * Presence of significant functional or structural abnormalities of the digestive system, including but not limited to congenital malformations, angiodysplasia, active peptic ulcer disease, chronic inflammatory or malabsorption disorders, hiatal hernia, or chronic gastroesophageal reflux. * High alcohol consumption, defined as \>14 units per week for women and \>20 units per week for men. * Pregnancy or lactation at the time of screening. * History of surgical procedures resulting in permanent alterations of the digestive system (e.g., gastroduodenostomy) or joint replacement surgery (hip or knee). * Diagnosis of arthritis. * History of any liver disease, with the exception of non-alcoholic fatty liver disease. * Diagnosis of any type of cancer, current cancer treatment, or history of cancer treatment within the past five years. * Known allergy or hypersensitivity to any component of the investigational product or to any food that could interfere with study participation and follow-up. * Presence of cognitive and/or psychological impairment that could affect study compliance. * Anticipated poor adherence or, in the opinion of the investigator, inability to comply with study procedures. * Engagement in night-shift work. * Current use of dietary supplements that may interfere with study outcomes (e.g., nutraceuticals containing compounds with potential weight loss effects). * Ongoing treatment for weight loss or diabetes.
๐Ÿ’Š

What it tests

  • Experimental Bar (Formulation 1) + Hypocaloric diet (10% energy restriction)
  • Experimental Bar (Formulation 2) + Hypocaloric diet (10% energy restriction)
  • Experimental Bar (Formulation 3) + Hypocaloric diet (10% energy restriction)
  • Placebo Bar + Hypocaloric diet (10% energy restriction)
๐Ÿ“

Where

1 site
Center for Nutrition Research
Pamplona, Spain
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy